Ruxillatinum Is Not Approved for ET

Ruxillatinum is not approved for ET but it does improve the symptoms no question about it if there is a drug for symptomatic ET patient that is not doing well on standard set reduction therapy then the ruxill platinum is to go to. The new agents are coming and here is the uh a pill that's a pill by medestad it does lower the platelets you can see  a night out of 10 patients will have a durable which is three months or more control of the platelet count below 400which is very good 90 percent. A study underway comparing aerobic interferon versus anagolite in the second setting for control of theplatelets and the white cells